Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5939)
All Articles published online
|
Publishing Process of This Article
|
Mar 22, 2015 (publication date) through May 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Toll A, Mané A. Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review. World J Psychiatr 2015; 5(1): 154-159 [PMID: 25815265 DOI: 10.5498/wjp.v5.i1.154] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v5/i1/154.htm |
| Number | Citing Articles |
| 1 |
Oliver D. Robertson, Nieves G. Coronado, Rickinder Sethi, Michael Berk, Seetal Dodd. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Intervention in Psychiatry 2019; 13(5): 1032 doi: 10.1111/eip.12775
|
| 2 |
Hedda Soloey-Nilsen, Kristin Nygaard-Odeh, Magnhild Gangsoey Kristiansen, Ole Lars Brekke, Tom Eirik Mollnes, Solveig Klaebo Reitan, Terje Oiesvold. Association between brain-derived neurotropic factor (BDNF), high-sensitivity C-reactive protein (hs-CRP) and psychiatric symptoms in medicated and unmedicated patients. BMC Psychiatry 2022; 22(1) doi: 10.1186/s12888-022-03744-2
|
| 3 |
Luisella Bocchio-Chiavetto, Roberta Zanardini, Sarah Tosato, Mariacarla Ventriglia, Clarissa Ferrari, Chiara Bonetto, Antonio Lasalvia, Franco Giubilini, Angelo Fioritti, Francesca Pileggi, Michela Pratelli, Michele Pavanati, Angela Favaro, Giovanni De Girolamo, Giovanni Battista Frisoni, Mirella Ruggeri, Massimo Gennarelli. Immune and metabolic alterations in first episode psychosis (FEP) patients. Brain, Behavior, and Immunity 2018; 70: 315 doi: 10.1016/j.bbi.2018.03.013
|
| 4 |
Ulrike Heitz, Martina Papmeyer, Erich Studerus, Laura Egloff, Sarah Ittig, Christina Andreou, Tobias Vogel, Stefan Borgwardt, Marc Graf, Anne Eckert, Anita Riecher-Rössler. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients. The World Journal of Biological Psychiatry 2019; 20(7): 545 doi: 10.1080/15622975.2018.1462532
|
| 5 |
I-Te Lee, Jun-Sing Wang, Chia-Po Fu, Shih-Yi Lin, Wayne Huey-Herng Sheu. Relationship between body weight and the increment in serum brain-derived neurotrophic factor after oral glucose challenge in men with obesity and metabolic syndrome. Medicine 2016; 95(43): e5260 doi: 10.1097/MD.0000000000005260
|
| 6 |
Raul Felipe Palma-Álvarez, Elena Ros-Cucurull, Kristopher Amaro-Hosey, Laia Rodriguez-Cintas, Lara Grau-López, Margarida Corominas-Roso, Cristina Sánchez-Mora, Carlos Roncero. Peripheral levels of BDNF and opiate-use disorder: literature review and update. Reviews in the Neurosciences 2017; 28(5): 499 doi: 10.1515/revneuro-2016-0078
|
| 7 |
Carlos Roncero, Raul Felipe Palma-Álvarez, Elena Ros-Cucurull, Carmen Barral, Begoña Gonzalvo, Margarida Corominas-Roso, Miguel Casas, Lara Grau-López. Cocaine-induced Psychosis and Brain-derived Neurothrophic Factor in Patients with Cocaine Dependence: Report of Two Cases. Clinical Psychopharmacology and Neuroscience 2016; 14(1): 109 doi: 10.9758/cpn.2016.14.1.109
|
| 8 |
Maria Skibinska, Pawel Kapelski, Aleksandra Rajewska-Rager, Aleksandra Szczepankiewicz, Beata Narozna, Joanna Duda, Bartłomiej Budzinski, Joanna Twarowska-Hauser, Monika Dmitrzak-Weglarz, Joanna Pawlak. Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.. Psychiatry Research 2019; 271: 89 doi: 10.1016/j.psychres.2018.11.041
|
| 9 |
Umit Haluk Yesilkaya, Sakir Gica, Pelin Ozkara Menekseoglu, Busra Guney Tasdemir, Zeynep Cirakli, Nesrin Karamustafalioglu. Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the “Beware the Ides of March” for Unaffected Relatives of Schizophrenia Patients?. Molecular Neurobiology 2022; 59(12): 7413 doi: 10.1007/s12035-022-03054-4
|
| 10 |
Jie Yin Yee, Tih-Shih Lee, Jimmy Lee. A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia. Journal of Clinical Psychopharmacology 2019; 39(6): 639 doi: 10.1097/JCP.0000000000001118
|
| 11 |
Partik Kaur, Virendra Singh Pal, Vijay Niranjan, Varchasvi Mudgal. Study of Brain-derived Neurotrophic Factor in Drug-naive Patients with Schizophrenia. Archives of Medicine and Health Sciences 2024; doi: 10.4103/amhs.amhs_225_23
|
| 12 |
Vicente Mustieles, Andrea Rodríguez-Carrillo, Fernando Vela-Soria, Shereen Cynthia D'Cruz, Arthur David, Fatima Smagulova, Antonio Mundo-López, Alicia Olivas-Martínez, Iris Reina-Pérez, Nicolás Olea, Carmen Freire, Juan P. Arrebola, Mariana F. Fernández. BDNF as a potential mediator between childhood BPA exposure and behavioral function in adolescent boys from the INMA-Granada cohort. Science of The Total Environment 2022; 803: 150014 doi: 10.1016/j.scitotenv.2021.150014
|
| 13 |
Jawahar Singh, Rohit Verma, Rahul Raghav, Siddharth Sarkar, Mamta Sood, Raka Jain. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study. Asian Journal of Psychiatry 2020; 54: 102370 doi: 10.1016/j.ajp.2020.102370
|
| 14 |
S. Kálmán, K.A. Garbett, Z. Janka, K. Mirnics. Human dermal fibroblasts in psychiatry research. Neuroscience 2016; 320: 105 doi: 10.1016/j.neuroscience.2016.01.067
|
| 15 |
Alba Toll, Laura Blanco-Hinojo, Daniel Berge, Ana Manzano, Khadija El Abidi, Víctor Perez-Solà, Anna Mané. Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients. Frontiers in Psychiatry 2023; 14 doi: 10.3389/fpsyt.2023.1301714
|
| 16 |
Charlotte Vrijen, Hendrika M. Schenk, Catharina A. Hartman, Albertine J. Oldehinkel. Measuring BDNF in saliva using commercial ELISA: Results from a small pilot study. Psychiatry Research 2017; 254: 340 doi: 10.1016/j.psychres.2017.04.034
|
| 17 |
Kenji Sanada, Sonia Ruiz de Azúa, Shinichiro Nakajima, Susana Alberich, Amaia Ugarte, Jone Zugasti, Patricia Vega, Mónica Martínez-Cengotitabengoa, Ana González-Pinto. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study. Psychiatry Research 2018; 268: 1 doi: 10.1016/j.psychres.2018.06.053
|
| 18 |
V. M. Ushakova, A. Yu. Morozova, A. M. Reznik, G. P. Kostyuk, V. P. Chekhonin. Molecular Biological Aspects of Depressive Disorders: A Modern View. Molecular Biology 2020; 54(5): 639 doi: 10.1134/S0026893320050118
|
| 19 |
Jessica L. Gören. Brain-derived neurotrophic factor and schizophrenia. Mental Health Clinician 2016; 6(6): 285 doi: 10.9740/mhc.2016.11.285
|
| 20 |
A Cattaneo, N Cattane, V Begni, C M Pariante, M A Riva. The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Translational Psychiatry 2016; 6(11): e958 doi: 10.1038/tp.2016.214
|
| 21 |
Umit Haluk Yesilkaya, Sakir Gica, Busra Guney Tasdemir, Pelin Ozkara Menekseoglu, Zeynep Cirakli, Nesrin Karamustafalioglu. A novel commentary: Investigation of the role of a balance between neurotrophic and apoptotic proteins in the pathogenesis of psychosis via the tPA-BDNF pathway. Journal of Psychiatric Research 2021; 142: 160 doi: 10.1016/j.jpsychires.2021.07.056
|
| 22 |
Jie Yin Yee, Tih-Shih Lee, Jimmy Lee. Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis—Findings from the Longitudinal Youth at Risk Study (LYRIKS). International Journal of Neuropsychopharmacology 2018; 21(8): 734 doi: 10.1093/ijnp/pyy036
|
| 23 |
Yu-Jie Chiou, Tiao-Lai Huang. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics. The World Journal of Biological Psychiatry 2017; 18(5): 382 doi: 10.1080/15622975.2016.1224925
|
| 24 |
Emily Fisher, Stephen J. Wood, Richard J. Elsworthy, Rachel Upthegrove, Sarah Aldred. Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study. Translational Psychiatry 2020; 10(1) doi: 10.1038/s41398-020-00927-x
|
| 25 |
Ming-Hua Duan, Li-Na Wang, Yan-Hong Jiang, Ying-Yuan Pei, Dong-Dong Guan, Zhi-Dong Qiu. Angelica sinensis reduced Aβ-induced memory impairment in rats. Journal of Drug Targeting 2016; 24(4): 340 doi: 10.3109/1061186X.2015.1077848
|
| 26 |
Mariane Nunes Noto, Michael Maes, Sandra Odebrecht Vargas Nunes, Vanessa Kiyomi Ota, Daniel Cavalcante, Giovany Oliveira, Ana C. Rossaneis, Waldiceu A. Verri, Quirino Cordeiro, Sintia Iole Belangero, Ary Gadelha, Cristiano Noto, Rodrigo Affonseca Bressan. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system. Journal of Psychiatric Research 2021; 141: 206 doi: 10.1016/j.jpsychires.2021.07.011
|
| 27 |
Mehmet Sinan Aydın, Abdullah Bolu, Muhammed Fevzi Kılınçkaya, Taner Öznur, Cemil Çelik, Özcan Uzun, Kamil Nahit Özmenler. Brain‐derived neurotrophic factor levels and psychopathology scores in drug‐naïve first‐episode psychosis. Asia-Pacific Psychiatry 2020; 12(4) doi: 10.1111/appy.12415
|
| 28 |
Skylar Kelsven, Camilo de la Fuente-Sandoval, Cristian L. Achim, Francisco Reyes-Madrigal, Heline Mirzakhanian, Isabel Domingues, Kristin Cadenhead. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness. Schizophrenia Research 2020; 226: 13 doi: 10.1016/j.schres.2020.01.003
|
| 29 |
A. Toll, D. Bergé, K. Burling, L. Scoriels, D. Treen, C. Monserrat, F. Marmol, X. Duran, P. B. Jones, V. Pérez-Solà, E. Fernandez-Egea, A. Mané. Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis. European Archives of Psychiatry and Clinical Neuroscience 2020; 270(7): 851 doi: 10.1007/s00406-020-01117-y
|